A “fully integrated, wearable” continuous glucose monitor (CGM) is set to transform diabetes care, researchers have said.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...
The monitors - which Pharmac is now funding for all type 1 diabetics - mean patients are less likely to suffer early deaths, ...
Today, DexCom is the leading CGM company, with an estimated 40% market share. Importantly, CGM products are relatively nascent. DexCom generates nearly $4 billion in annual sales on a user base of ...
We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to ...
The company’s FreeStyle Libre continuous glucose monitoring system has been a game-changer in diabetes management. This device allows patients to monitor their glucose levels without painful ...
Ascensia Diabetes Care, a global diabetes care company, announces that it is launching the Eversense® 365 continuous glucose monitoring (CGM) system, the world's only One Year CGM, to people with ...
Lana Reed makes dreams come true. Part of the Pinnacle Tairāwhiti care co-ordinator’s job is to equip individuals with the ...
GlobalData on MSN17h
Medtronic shares dip after FDA tags insulin pump recall as Class IMedtronic found that dropping, bumping, or hits to the MiniMed device could result in a shortened battery life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback